Business
Peter Menziuso Named EVP and President, BD Interventional
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1.
About this update from Becton, Dickinson And Company
[{"type":"text","content":"FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1.","length":271,"tagName":"p"},{"type":"image","alt":"Peter Menziuso, Executive Vice President and President, BD Interventional","displaySize":"","headline":null,"caption":"Peter Menziuso, Executive Vice President and President, BD Interventional","className":"","disableSlideshowImg":false,"size":{"original":{"width":1280,"height":720,"url":"https://mma.prnewswire.com/media/2981701/Peter_Menziuso_BD.jpg"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.jWG6Qqj.Lf_A6MXOytp0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MA--/https://mma.prnewswire.com/media/2981701/Peter_Menziuso_BD.jpg","width":960,"height":540},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/2ez49aryCUyesqI8D5bo7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM2MA--/https://mma.prnewswire.com/media/2981701/Peter_Menziuso_BD.jpg","width":640,"height":360},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/8mvotGV9ACcPvf8T3AR6pw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUw/https://mma.prnewswire.com/media/2981701/Peter_Menziuso_BD.jpg","width":1200,"height":675}},"href":"https://mma.prnewswire.com/media/2981701/Peter_Menziuso_BD.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Menziuso brings more than 30 years of global healthcare leadership experience and a strong track record of driving growth through disciplined execution. He most recently served as Company Group Chairman of Johnson & Johnson Vision, where he led a $5 billion global business with responsibility for commercial operations, R&D, supply chain, quality, finance and medical affairs.","length":385,"tagName":"p"},{"type":"text","content":"Throughout his career, Menziuso has been recognized for strengthening market leadership, building high‑performing teams and translating strategy into sustained performance through commercial rigor and operational excellence. His global leadership experience, coupled with his customer obsession and ability to lead at scale position him well to accelerate execution and deliver continued growth for BD Interventional.","length":417,"tagName":"p"},{"type":"text","content":""BD In...